Advertisement

Of Wind and Water

  • Mark T. Friedman
  • Kamille A. West
  • Peyman Bizargity
  • Kyle Annen
  • Jeffrey S. Jhang
Chapter

Abstract

A 65-year-old man with a history of obesity, type 2 diabetes mellitus, chronic anemia, and renal insufficiency is admitted to the hospital for evaluation of worsening renal failure, a drop in the hemoglobin (Hgb) level, dyspnea on exertion, and fatigue. The patient’s Hgb is 6.2 g/dL (his baseline is 8.0 g/dL), and the creatinine is 4.4 mg/dL on admission. The patient is tachypneic (respiratory rate is greater than 20 breaths/min) and hypoxic (oxygen saturation is 88% on room air). He is treated with supplemental oxygen 2 L/min by nasal cannula and normal saline by slow intravenous (IV) infusion (125 mL/h). A consult is called for evaluation of gastrointestinal bleeding. In the meantime, a type and screen sample (ethylenediaminetetraacetic acid [EDTA] anticoagulant) is submitted to the blood bank along with a request for two units of red blood cells (RBCs). The patient received RBC transfusion of two units 3 years ago at the hospital; the antibody screen was negative at that time.

Keywords

Acute lung injury/ALI Adult respiratory distress syndrome/ARDS Biologic response modifiers (BRMs) Brain natriuretic peptide/BNP HLA antibodies Human neutrophil antigen antibodies Transfusion-associated circulatory overload/TACO Transfusion-related acute lung injury/TRALI 

References

  1. 1.
    Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19(1):2–31.CrossRefPubMedGoogle Scholar
  2. 2.
    Teke HÜ, Behret O, Teke D. Transfusion-related acute lung injury. Indian J Hematol Blood Transfus. 2014;30(1):56–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Association Bulletin #14-02. TRALI risk mitigation for plasma and whole blood for allogeneic transfusion. Bethesda, MD: AABB; 29 Jan 2014. Available at: https://www.aabb.org/programs/publications/bulletins/Documents/ab14-02.pdf. Accessed 10 Feb 2018.
  4. 4.
    Ganguly S, Carrum G, Nizzi F, Heslop H, Popat U. Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia. Am J Hematol. 2003;75(1):48–51.CrossRefGoogle Scholar
  5. 5.
    Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009;23(6):245–55.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Shaz BH, Stowell SR, Hillyer CD. Transfusion-related acute lung injury: from bedside to bench and back. Blood. 2011;117(5):1463–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Pham HP, Spitalnik SL. Approach to the diagnosis and management of transfusion-related acute lung injury. Ask the Hematologist. 2013;10(4). Available at: http://www.hematology.org/Thehematologist/Ask/1046.aspx. Accessed 10 Feb 2018.
  8. 8.
    Clifford L, Kor DJ. Transfusion-associated circulatory overload. In: Juffermans N, Walsh T, editors. Transfusion in the intensive care unit. Switzerland: Springer International Publishing; 2015. p. 171–82.Google Scholar

Recommended Reading

  1. Pham HP, Spitalnik SL. Approach to the diagnosis and management of transfusion-related acute lung injury. Ask the Hematologist. 2013;10(4). Available at: http://www.hematology.org/Thehematologist/Ask/1046.aspx.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mark T. Friedman
    • 1
  • Kamille A. West
    • 2
  • Peyman Bizargity
    • 3
  • Kyle Annen
    • 4
  • Jeffrey S. Jhang
    • 1
  1. 1.Icahn School of MedicineMount Sinai Health SystemNew YorkUSA
  2. 2.Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesdaUSA
  3. 3.Department of Molecular & Human GeneticsBaylor College of MedicineHoustonUSA
  4. 4.Department of PathologyChildren’s Hospital ColoradoAuroraUSA

Personalised recommendations